血液濾過・浄化の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

血液濾過・浄化市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の血液濾過・浄化市場規模は2030年までに56億3,000万米ドルに達すると予測され、2025～2030年にかけてCAGR 7.34％で成長すると予測されています。

血液を媒介とする疾患の有病率の増加、高齢者の増加、血液浄化療法に対する意識の高まりなどの主要促進要因が、市場成長に拍車をかけています。

臨床診断における血液濾過・浄化産業は、COVID-19パンデミックの間に大きな急増を経験し、重篤な患者に対する効果的な治療ソリューションに対する緊急の必要性に後押しされました。この時期に最も重要なツールとなったのが、先進的血液浄化キットであり、重症の炎症反応、臓器不全、ウイルスに伴う合併症の管理に重要な役割を果たしました。

この技術革新の最前線にあったのが、多機能血液浄化フィルターセットであるOXIRISで、血液中のサイトカインや炎症性メディエーターを除去すると同時に、持続的腎代替療法（CRRT）を実施できる米国で唯一の製品でした。パンデミックの最中、OXIRISはサイトカインストーム、敗血症、急性腎障害に見舞われた重篤なCOVID-19患者を管理するための重要な治療ソリューションとなりました。炎症性物質を効率的に除去することで、このキットは患者を安定させ、集中治療の負担を軽減し、生存転帰を改善するのに役立ちました。

サーモサイエンティフィックのGeneJET全血ゲノムDNA浄化ミニキットは、迅速なスピンカラムベースのシリカ膜技術で際立っています。このキットは全血からのDNA抽出を合理化し、危険なフェノール-クロロホルム抽出や時間のかかるアルコール沈殿を不要にします。標準的なプロトコールでは溶解後20分以下で、PCR、サザンブロッティング、酵素アッセイなどの下流のアプリケーションに適した高分子量DNA（>30 kb）が得られます。このキットはシンプルで信頼性が高いため、迅速かつ安全にゲノム診断の規模を拡大したいラボに最適です。

SpiNXT Blood DNA Extraction Kitはもう一つの革新的なソリューションで、全血、血漿、血清、リンパ球、バフィーコートに使用できるように設計されています。シリカ結合ケミストリーとミニスピンカラムフォーマットを組み合わせることで、様々な血液由来のサンプルタイプにおいて、高収率、高純度のDNA単離を実現します。有機溶媒や複雑な装置を必要としないSpiNXTキットは、迅速な処理を可能にし、幅広い臨床遺伝子アッセイに適合します。

一方、sbeadex Blood DNA Purification Kitは、磁性ビーズベースの技術に焦点を当てたものです。200μLまでのサンプル量用に設計されたこのキットは、高性能オートメーションワークフローをサポートし、サーモフィッシャー社のKingFisher（TM）システムのような一般的なプラットフォームと完全に互換性があります。水ベースの洗浄バッファーにより、有機溶媒やPCR阻害剤のキャリーオーバーを排除し、qPCR、NGS、サンガーシーケンス、遺伝子疾患スクリーニングなどの高感度アプリケーションに適したクリーンなDNAを確保することができます。

パンデミックは、高リスク患者の管理における血液浄化キットの重要な役割を浮き彫りにしました。ヘルスケアシステムがCOVID-19の課題に適応するにつれ、これらのキットは診断支援だけでなく治療介入にも不可欠なツールとなりました。その影響はパンデミックを超えて拡大し、敗血症、腎障害、その他の炎症に起因する病態の管理に使われ続けています。

COVID-19危機は、OXIRIS、CytoSorb、AMBER、Hemoclearなどの血液濾過・浄化キットの採用を加速させ、統合臨床診断とクリティカルケアの新たな基準を打ち立てた。これらの技術革新は、現代のICU診療の中心であり続け、パンデミック時に学んだ教訓を、今後より強力で対応力の高いヘルスケアシステムに確実に反映させています。

血液濾過・浄化市場レポートハイライト

• 2024年には、濾過キット・試薬部門が35.97%の最大売上シェアで市場をリードしました。このセグメントは、輸血、治療、医療研究の安全性と有効性を確保する上で重要な役割を担っているため、急速な拡大が見込まれています。主要な促進要因は、濾過材料の技術的進歩であり、高品質の血液製剤に対する世界の需要の高まりが、濾過キットと試薬市場の優位性をさらに高めています。
• 用途別では、感染症診断セグメントが2024年に最大の市場収益シェアを占めました。これは、感染症の世界の流行が拡大していることと、正確で迅速な診断が切実に求められているためです。遺伝子/分子診断セグメントは、正確で個別化されたヘルスケアソリューションに対する需要の高まりにより、予測期間中に最も速いCAGRで成長する見込みです。
• 最終用途別では、臨床診断ラボセグメントが2024年に最大の市場収益シェアを占めました。これは、病気の検出とモニタリングに不可欠な役割を果たすためです。これらの検査室は、特に感染症診断、遺伝子検査、腫瘍学において、正確な検査のために高品質で汚染のない血液サンプルを得るために先進的濾過技術に依存しています。個別化医療と疾患の早期発見の増加に伴い、臨床診断ラボは最先端の濾過技術を採用しており、この市場セグメントの規模と成長を牽引しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 血液濾過・浄化市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 血液濾過・浄化市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 血液濾過・浄化市場：製品別、推定・動向分析

• 血液濾過・浄化市場：製品ダッシュボード
• 世界の血液濾過・浄化市場の製品変動分析
• 世界の血液濾過・浄化市場：製品別展望
• 濾過キットと試薬
• 膜、フィルター、消耗品
• サンプル調製システム
• 特殊アッセイとカラム

第5章 血液濾過・浄化市場：用途別、推定・動向分析

• 血液濾過・浄化市場：用途ダッシュボード
• 世界の血液濾過・浄化市場の用途変動分析
• 世界の血液濾過・浄化市場：用途別展望
• 感染症診断
• 毒物学と免疫診断学
• がん診断
• 遺伝子/分子診断
• その他（代謝、希少疾患パネル）

第6章 血液濾過・浄化市場：最終用途別、推定・動向分析

• 血液濾過・浄化市場：最終用途ダッシュボード
• 世界の血液濾過・浄化市場の最終用途変動分析
• 世界の血液濾過・浄化市場：最終用途別展望
• 臨床診断
• 病院
• 研究・学術機関
• その他

第7章 血液濾過・浄化市場：製品、用途、最終用途による地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店とチャネルパートナー一覧
  • 主要企業の市場シェア分析、2024年
  • Thermo Fischer Scientific
  • MilliporeSigma
  • Roche Lifescience
  • Sigma Aldrich
  • Avantor.
  • Takara Bio
  • MP Biomedicals
  • QIAGEN NV
  • HiMedia
  • BIoTage

List of Tables

• Table. 1. List of abbreviation
• Table. 2. North America blood filtration & purification market, by region, 2018 - 2030 (USD Million)
• Table. 3. North America blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 4. North America blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 5. North America blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 6. U.S. blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 7. U.S. blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 8. U.S. blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 9. Canada blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 10. Canada blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 11. Canada blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 12. Mexico blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 13. Mexico blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 14. Mexico blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 15. Europe blood filtration & purification market, by region, 2018 - 2030 (USD Million)
• Table. 16. Europe blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 17. Europe blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 18. Europe blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 19. Germany blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 20. Germany blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 21. Germany blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 22. UK blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 23. UK blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 24. UK blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 25. France blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 26. France blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 27. France blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 28. Italy blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 29. Italy blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 30. Italy blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 31. Spain blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 32. Spain blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 33. Spain blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 34. Denmark blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 35. Denmark blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 36. Denmark blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 37. Sweden blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 38. Sweden blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 39. Sweden blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 40. Norway blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 41. Norway blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 42. Norway blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 43. Asia Pacific blood filtration & purification market, by region, 2018 - 2030 (USD Million)
• Table. 44. Asia Pacific blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 45. Asia Pacific blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 46. Asia Pacific blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 47. China blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 48. China blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 49. China blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 50. Japan blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 51. Japan blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 52. Japan blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 53. India blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 54. India blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 55. India blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 56. South Korea blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 57. South Korea blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 58. South Korea blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 59. Australia blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 60. Australia blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 61. Australia blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 62. Thailand blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 63. Thailand blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 64. Thailand blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 65. Latin America blood filtration & purification market, by region, 2018 - 2030 (USD Million)
• Table. 66. Latin America blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 67. Latin America blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 68. Latin America blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 69. Brazil blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 70. Brazil blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 71. Brazil blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 72. Mexico blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 73. Argentina blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 74. Argentina blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 75. Argentina blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 76. MEA blood filtration & purification market, by region, 2018 - 2030 (USD Million)
• Table. 77. MEA blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 78. MEA blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 79. MEA blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 80. South Africa blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 81. South Africa blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 82. South Africa blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 83. Saudi Arabia blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 84. Saudi Arabia blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 85. Saudi Arabia blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 86. UAE blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 87. UAE blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 88. UAE blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
• Table. 89. Kuwait blood filtration & purification market, by product, 2018 - 2030 (USD Million)
• Table. 90. Kuwait blood filtration & purification market, by application, 2018 - 2030 (USD Million)
• Table. 91. Kuwait blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Blood filtration & purification market: market outlook
• Fig. 14 Blood filtration & purification competitive insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Blood filtration & purification market driver impact
• Fig. 18 Blood filtration & purification market restraint impact
• Fig. 19 Blood filtration & purification market: Product movement analysis
• Fig. 20 Blood filtration & purification market: Product outlook and key takeaways
• Fig. 21 Filtration kits and reagents estimates and forecast, 2018 - 2030
• Fig. 22 Membrane, filters and consumables estimates and forecast, 2018 - 2030
• Fig. 23 Sample Preparation Systems estimates and forecast, 2018 - 2030
• Fig. 24 Specialty Assays/Columns estimates and forecast, 2018 - 2030
• Fig. 25 Blood filtration & purification market: Application movement analysis
• Fig. 26 Blood filtration & purification market: Application outlook and key takeaways
• Fig. 27 Infectious Disease Diagnostics market estimates and forecast, 2018 - 2030
• Fig. 28 Toxicology and Immunodiagnostics estimates and forecast, 2018 - 2030
• Fig. 29 Cancer Diagnostics market estimates and forecast, 2018 - 2030
• Fig. 30 Genetic/Molecular Diagnostics market estimates and forecast, 2018 - 2030
• Fig. 31 Others estimates and forecast, 2018 - 2030
• Fig. 32 Blood filtration & purification market: End-use movement analysis
• Fig. 33 Blood filtration & purification market: End-use outlook and key takeaways
• Fig. 34 Clinical Diagnostics market estimates and forecast, 2018 - 2030
• Fig. 35 Hospitals estimates and forecast, 2018 - 2030
• Fig. 36 Research and Academic Institutes estimates and forecast, 2018 - 2030
• Fig. 37 Others market estimates and forecast, 2018 - 2030
• Fig. 38 Global blood filtration & purification market: Regional movement analysis
• Fig. 39 Global blood filtration & purification market: Regional outlook and key takeaways
• Fig. 40 Global blood filtration & purification market share and leading players
• Fig. 41 North America market estimates and forecasts, 2018 - 2030
• Fig. 42 US key country dynamics
• Fig. 43 US market estimates and forecasts, 2018 - 2030
• Fig. 44 Canada key country dynamics
• Fig. 45 Canada market estimates and forecasts, 2018 - 2030
• Fig. 46 Mexico key country dynamics, 2018 - 2030
• Fig. 47 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 48 Europe market estimates and forecasts, 2018 - 2030
• Fig. 49 UK key country dynamics
• Fig. 50 UK market estimates and forecasts, 2018 - 2030
• Fig. 51 Germany key country dynamics
• Fig. 52 Germany market estimates and forecasts, 2018 - 2030
• Fig. 53 France key country dynamics
• Fig. 54 France market estimates and forecasts, 2018 - 2030
• Fig. 55 Italy key country dynamics
• Fig. 56 Italy market estimates and forecasts, 2018 - 2030
• Fig. 57 Spain key country dynamics
• Fig. 58 Spain market estimates and forecasts, 2018 - 2030
• Fig. 59 Denmark key country dynamics
• Fig. 60 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 61 Sweden key country dynamics
• Fig. 62 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 63 Norway key country dynamics
• Fig. 64 Norway market estimates and forecasts, 2018 - 2030
• Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 66 China key country dynamics
• Fig. 67 China market estimates and forecasts, 2018 - 2030
• Fig. 68 Japan key country dynamics
• Fig. 69 Japan market estimates and forecasts, 2018 - 2030
• Fig. 70 India key country dynamics
• Fig. 71 India market estimates and forecasts, 2018 - 2030
• Fig. 72 Thailand key country dynamics
• Fig. 73 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 74 South Korea key country dynamics
• Fig. 75 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 76 Australia key country dynamics
• Fig. 77 Australia market estimates and forecasts, 2018 - 2030
• Fig. 78 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 79 Brazil key country dynamics
• Fig. 80 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 81 Argentina key country dynamics
• Fig. 82 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 84 South Africa key country dynamics
• Fig. 85 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 86 Saudi Arabia key country dynamics
• Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 88 UAE key country dynamics
• Fig. 89 UAE market estimates and forecasts, 2018 - 2030
• Fig. 90 Kuwait key country dynamics
• Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 92 Market share of key market players - Blood filtration & purification market

Blood Filtration And Purification Market Growth & Trends:

The global blood filtration and purification market size is anticipated to reach USD 5.63 billion by 2030 and is projected to grow at a CAGR of 7.34% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key driving factors such as increasing prevalence of blood-borne diseases, growing geriatric population, rising awareness of blood purification therapies have fueled the market growth.

The blood filtration & purification industry in clinical diagnostics experienced a major surge during the COVID-19 pandemic, driven by the urgent need for effective treatment solutions for critically ill patients. Among the most vital tools during this period were advanced blood purification kits, which played a critical role in managing severe inflammatory responses, organ failure, and complications associated with the virus.

At the forefront of this innovation was OXIRIS, a multifunctional blood purification filter set-the only one available in the U.S. capable of performing Continuous Renal Replacement Therapy (CRRT) while simultaneously removing cytokines and inflammatory mediators from the blood. During the height of the pandemic, OXIRIS became a key therapeutic solution for managing critically ill COVID-19 patients who were experiencing cytokine storms, sepsis, and acute kidney injury. By efficiently removing inflammatory substances, the kit helped stabilize patients, reduce intensive care burden, and improve survival outcomes.

Thermo Scientific's GeneJET Whole Blood Genomic DNA Purification Mini Kit stands out for its rapid, spin-column-based silica membrane technology. This kit streamlines DNA extraction from whole blood, eliminating the need for hazardous phenol-chloroform extraction or time-consuming alcohol precipitation. With a standard protocol that takes under 20 minutes post-lysis, it delivers high molecular weight DNA (>30 kb), ready for downstream applications like PCR, Southern blotting, and enzymatic assays. The kit's simplicity and reliability make it a preferred choice for laboratories looking to scale genomic diagnostics with speed and safety.

SpiNXT Blood DNA Extraction Kit is another innovative solution, designed for use with whole blood, plasma, serum, lymphocytes, and buffy coat. Combining silica-binding chemistry with a mini spin-column format, it ensures high-yield, high-purity DNA isolations across a range of blood-derived sample types. With no need for organic solvents or complicated equipment, the SpiNXT kit enables fast processing and compatibility with a wide array of clinical genetic assays.

Meanwhile, the sbeadex Blood DNA Purification Kit brings magnetic bead-based technology into focus. Designed for sample volumes up to 200 µL, the kit supports high-throughput automation workflows and is fully compatible with popular platforms like Thermo Fisher's KingFisher(TM) system. Its water-based wash buffers help eliminate carryover of organic solvents and PCR inhibitors, ensuring clean DNA suitable for sensitive applications such as qPCR, NGS, Sanger sequencing, and genetic disorder screening.

The pandemic highlighted the critical role of blood purification kits in managing high-risk patients. As healthcare systems adapted to the challenges of COVID-19, these kits became indispensable tools not only for diagnostic support but also for therapeutic intervention. Their impact has extended beyond the pandemic, with continued use in managing sepsis, kidney injury, and other inflammation-driven conditions.

The COVID-19 crisis accelerated the adoption of blood filtration and purification kits such as OXIRIS, CytoSorb, AMBER, and Hemoclear, setting a new benchmark for integrated clinical diagnostics and critical care. These innovations remain central to modern ICU practice, ensuring that the lessons learned during the pandemic translate into stronger, more responsive healthcare systems going forward.

Blood Filtration And Purification Market Report Highlights:

• The filtration kits & reagents segment led the market with the largest revenue share of 35.97% in 2024. This segment is expected to see rapid expansion due to its critical role in ensuring the safety and efficacy of blood transfusions, therapeutic treatments, and medical research. A key driving factor is the technological advancements in filtration materials, and a growing global demand for high-quality blood products further contributes to the dominance of filtration kits and reagents in the market.
• Based on application, the infectious disease diagnostics segment accounted for the largest market revenue share in 2024, due to the growing global prevalence of infectious diseases and the critical need for accurate, rapid diagnostics. The genetic/molecular diagnostics segment is expected to grow at the fastest CAGR over the forecast period, due to the increasing demand for precise, personalized healthcare solutions.
• Based on end use, the clinical diagnostics laboratories segment accounted for the largest market revenue share in 2024, due to their essential role in disease detection and monitoring. These laboratories rely on advanced filtration technologies to obtain high-quality, contaminant-free blood samples for accurate testing, especially in infectious disease diagnostics, genetic testing, and oncology. With the rise of personalized medicine and early disease detection, clinical diagnostic labs are adopting cutting-edge filtration technologies, driving both the size and growth of this market segment.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End-use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Blood Filtration & Purification Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD)
    • 3.2.1.2. Increasing prevalence of bloodborne diseases
    • 3.2.1.3. Advancements in hemodialysis and renal care
    • 3.2.1.4. Rising Demand for safe blood transfusions
    • 3.2.1.5. Technological advancements in filtration and purification systems
    • 3.2.1.6. Growing use of liquid biopsy for cancer diagnostics
    • 3.2.1.7. Regulatory push for improved blood safety standards
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High equipment costs
    • 3.2.2.2. Lack of awareness and skilled professionals
• 3.3. Blood Filtration & Purification Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Blood Filtration & Purification Market: Product Estimates & Trend Analysis

• 4.1. Blood Filtration & Purification Market: Product Dashboard
• 4.2. Global Blood Filtration & Purification Market Product Movement Analysis
• 4.3. Global Blood Filtration & Purification Market by Product Outlook
• 4.4. Filtration kits and Reagents
  • 4.4.1. Filtration kits and Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Membranes, Filters and Consumables
  • 4.5.1. Membranes, Filters and Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Sample preparation systems
  • 4.6.1. Sample preparation systems market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Specialty assays and columns
  • 4.7.1. Specialty assays and columns market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Blood Filtration & Purification Market: Application Estimates & Trend Analysis

• 5.1. Blood Filtration & Purification Market: Application Dashboard
• 5.2. Global Blood Filtration & Purification Market Application Movement Analysis
• 5.3. Global Blood Filtration & Purification Market by Application Outlook
• 5.4. Infectious Disease Diagnostics
  • 5.4.1. Infectious Disease Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Toxicology and Immunodiagnostics
  • 5.5.1. Toxicology and Immunodiagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Cancer Diagnostics
  • 5.6.1. Cancer Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.7. Genetic/Molecular Diagnostics
  • 5.7.1. Genetic/Molecular Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)
• 5.8. Others (Metabolic, Rare Disease Panels
  • 5.8.1. Genetic/Molecular Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 6. Blood Filtration & Purification Market: End-use Estimates & Trend Analysis

• 6.1. Blood Filtration & Purification Market: End-use Dashboard
• 6.2. Global Blood Filtration & Purification Market End-use Movement Analysis
• 6.3. Global Blood Filtration & Purification Market by End-use Outlook
• 6.4. Clinical Diagnostics
  • 6.4.1. Clinical Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Research and Academic Institutes
  • 6.6.1. Research and Academic Institutes market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Blood Filtration & Purification Market: Regional Estimates & Trend Analysis by Product, Application and End-use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2024
  • 8.3.4. Thermo Fischer Scientific
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. MilliporeSigma
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Roche Lifescience
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Sigma Aldrich
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Avantor.
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Takara Bio
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. MP Biomedicals
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. QIAGEN N.V
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. HiMedia
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Biotage
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives